Henrik Hasle
#154,061
Most Influential Person Now
Researcher
Henrik Hasle's AcademicInfluence.com Rankings
Henrik Haslecomputer-science Degrees
Computer Science
#8326
World Rank
#8753
Historical Rank
Machine Learning
#3383
World Rank
#3424
Historical Rank
Artificial Intelligence
#3681
World Rank
#3734
Historical Rank
Database
#5347
World Rank
#5549
Historical Rank
Download Badge
Computer Science
Why Is Henrik Hasle Influential?
(Suggest an Edit or Addition)Henrik Hasle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia (2003) (955)
- Risks of leukaemia and solid tumours in individuals with Down's syndrome (2000) (803)
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. (2012) (454)
- A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases (2003) (405)
- Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases. (1997) (386)
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia (2010) (303)
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. (2005) (301)
- Nathan and Oski’s Hematology of Infancy and Childhood (2010) (281)
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. (2009) (275)
- Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. (2016) (274)
- Pattern of malignant disorders in individuals with Down's syndrome. (2001) (263)
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. (2015) (245)
- Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) (1997) (238)
- The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. (2005) (234)
- Cancer incidence in men with Klinefelter syndrome. (1995) (229)
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. (2009) (225)
- WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single‐centre study (2004) (210)
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes (2011) (197)
- Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. (2013) (190)
- RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML) (1999) (189)
- Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. (2006) (186)
- Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. (2011) (179)
- Efficacy of anti-IL-1 treatment in Majeed syndrome (2012) (163)
- Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials (2005) (147)
- Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. (2009) (143)
- Acute leukaemia in children with Down syndrome: a population‐based Nordic study (2005) (143)
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7 (1999) (138)
- Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. (2007) (138)
- Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. (2003) (137)
- Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO‐AML trials (2003) (133)
- Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias. (2010) (132)
- Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. (1995) (127)
- Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. (2010) (119)
- Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. (2003) (116)
- Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. (1997) (112)
- Myelodysplastic syndromes in childhood--classification, epidemiology, and treatment. (1994) (109)
- Low risk of solid tumors in persons with Down syndrome (2016) (104)
- Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. (2011) (102)
- Occurrence of cancer in women with Turner syndrome. (1996) (102)
- Treatment‐related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001 (2005) (101)
- A population‐based study of childhood myelodysplastic syndrome in British Columbia, Canada (1999) (101)
- Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004. (2011) (100)
- Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. (2011) (97)
- Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. (2010) (96)
- Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia (2011) (95)
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. (2011) (89)
- Childhood cancer survivor cohorts in Europe (2015) (89)
- Improved outcome after relapse in children with acute myeloid leukaemia (2007) (88)
- The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) (2004) (88)
- Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations (2010) (85)
- Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark (2002) (84)
- Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. (2011) (81)
- Childhood cancer: Survival, treatment modalities, late effects and improvements over time. (2020) (79)
- Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals (2008) (78)
- Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia (2005) (76)
- Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study (2014) (76)
- Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 (2017) (75)
- Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. (2010) (74)
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study (2010) (73)
- Few but severe viral infections in children with cancer: A prospective RT‐PCR and PCR‐based 12‐month study (2005) (73)
- RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia (2017) (70)
- Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. (1996) (70)
- Survival among people with Down syndrome: a nationwide population-based study in Denmark (2012) (70)
- Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population‐based cohort study of 32,308 one‐year survivors (2015) (70)
- Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. (2012) (69)
- Non‐hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: A retrospective analysis and definition of response criteria (2007) (69)
- Evidence of decreased risk of cancer in individuals with fragile X. (2001) (66)
- Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors (2017) (66)
- A critical review of which children with acute myeloid leukaemia need stem cell procedures (2014) (66)
- Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. (2008) (66)
- t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients (2014) (66)
- Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML (2008) (65)
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. (2011) (65)
- Classification of treatment-related mortality in children with cancer: a systematic assessment. (2015) (65)
- Malignant Diseases in Noonan Syndrome and Related Disorders (2009) (64)
- Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature (2006) (64)
- Advances in the prognostication and management of advanced MDS in children (2011) (64)
- Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study (2016) (63)
- Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood. (2014) (62)
- Incidence of essential thrombocythaemia in children (2000) (61)
- Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency. (1994) (60)
- Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. (2012) (60)
- Chronic neutrophil leukaemia in adolescence and young adulthood (1996) (60)
- Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. (2015) (59)
- Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. (2015) (58)
- Mediastinal germ cell tumour associated with Klinefelter syndrome (1992) (57)
- Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse. (2006) (55)
- Myelodysplastic and myeloproliferative disorders of childhood. (2016) (55)
- Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1 (2010) (54)
- Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice. (1997) (54)
- Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. (1998) (54)
- Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. (2017) (53)
- Myelodysplastic syndromes in childhood: a population based study of nine cases (1992) (53)
- Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia (2007) (50)
- Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype. (1995) (50)
- Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO‐AML study (2011) (49)
- LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. (2016) (48)
- Early and treatment‐related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003 (2010) (47)
- The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) Study: Design and Characteristics (2015) (47)
- Transient pancytopenia preceding acute lymphoblastic leukemia (pre-ALL). (1995) (44)
- A cohort study on cancer incidence among Danish gardeners. (1992) (44)
- Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (43)
- Extramedullary leukemia in children with acute myeloid leukemia: A population‐based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2017) (43)
- Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes (2018) (43)
- Arthritis as presenting manifestation of acute lymphoblastic leukaemia in children (2015) (43)
- Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. (2018) (41)
- Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. (2007) (39)
- The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01 (2014) (39)
- Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda (2014) (38)
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia (2015) (38)
- Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. (2018) (37)
- Treatment of the X‐linked lymphoproliferative, Griscelli and Chédiak–Higashi syndromes by HLH directed therapy (2009) (37)
- Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood (2014) (36)
- A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era (2021) (36)
- Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes (2020) (36)
- Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood (2014) (36)
- Genetic and epigenetic similarities and differences between childhood and adult AML (2012) (35)
- Merkel cell carcinoma: the role of primary treatment with radiotherapy. (1991) (35)
- The t(X;7)(q22;q34) in paediatric T‐cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T‐cell receptor beta locus (2009) (33)
- Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy (2017) (33)
- Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. (1996) (33)
- Myelodysplastic and myeloproliferative disorders in children (2007) (33)
- Hospitalizations among people with Down syndrome: A nationwide population‐based study in Denmark (2013) (33)
- RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia (2014) (32)
- Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO‐AML study (2014) (31)
- Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome (2007) (30)
- Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications (2006) (30)
- Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy (2013) (30)
- Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. (2008) (29)
- Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004 (2016) (29)
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study (2014) (28)
- Therapy with low‐dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG‐MDS study group (2016) (28)
- A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome. (2008) (27)
- Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia (2017) (27)
- Study protocol: rehabilitation including social and physical activity and education in children and teenagers with cancer (RESPECT) (2013) (26)
- Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO‐AML study (2013) (25)
- Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study (2019) (25)
- High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine (2013) (25)
- Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. (2020) (25)
- Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia (2007) (25)
- Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes? (2011) (24)
- Presence of FLT 3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia * (2011) (24)
- Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency (2020) (23)
- Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. (2020) (23)
- Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia (2011) (22)
- Occurrence of cancer in a cohort of 183 persons with constitutional chromosome 7 abnormalities. (1998) (22)
- Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome (2007) (22)
- The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS (2014) (21)
- Risk of cancer in children with the diagnosis immaturity at birth. (2006) (21)
- Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods (2012) (20)
- A review of anti‐D treatment of childhood idiopathic thrombocytopenic purpura (2006) (19)
- Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO–AML Study (2018) (19)
- Extreme doses of intravenous methadone for severe pain in two children with cancer (2015) (19)
- Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (2020) (18)
- Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood (2013) (18)
- FAMily-Oriented Support (FAMOS): development and feasibility of a psychosocial intervention for families of childhood cancer survivors (2017) (18)
- The applicability of the WHO classification in paediatric AML. A NOPHO‐AML study (2015) (18)
- Cerebellar toxicity during cytarabine therapy associated with renal insufficiency (2004) (17)
- Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries (2016) (17)
- A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries (2013) (17)
- Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and Denmark. (2013) (17)
- Hodgkin's disease diagnosed post mortem: a population based study. (1993) (17)
- Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome (2021) (17)
- Association between living conditions in childhood and myocardial infarction. (1990) (17)
- Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS) (2015) (16)
- Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia (1997) (16)
- Congenital anemia caused by parvovirus B19 infection. (2000) (16)
- Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO‐AML study (2016) (15)
- GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis. (2005) (15)
- Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only—A NOPHO‐AML study (2014) (15)
- Strategies for reducing the treatment‐related physical burden of childhood acute myeloid leukaemia – a review (2017) (15)
- High frequency of copy number alterations in myeloid leukaemia of Down syndrome (2012) (14)
- Population‐based study of cancer among carriers of a constitutional structural chromosomal rearrangement (2006) (14)
- Unexpected High Frequency of GATA2 Mutations in Children with Non-Familial MDS and Monosomy 7 (2012) (14)
- Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO‐AML) and review of the literature (2018) (14)
- Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study (2018) (14)
- Subcutaneous anti‐D treatment of idiopathic thrombocytopenic purpura in children (2009) (14)
- Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate‐risk acute myeloid leukemia (2012) (14)
- WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder. (2006) (14)
- Long-term risk of renal and urinary tract diseases in childhood cancer survivors: A population-based cohort study. (2016) (13)
- JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia (2007) (13)
- Pediatric myelodysplastic syndromes (2005) (13)
- Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency (2015) (13)
- Origin of male mediastinal germ-cell tumours (1995) (13)
- Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial (2020) (13)
- Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia (2020) (12)
- Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups (2017) (12)
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leykemia (2003) (12)
- Outcome of poor response paediatric AML using early SCT (2012) (12)
- [Incidence of cancer in individuals with Down syndrome]. (2000) (12)
- Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement (2017) (12)
- A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia (2006) (12)
- [The significance of childhood conditions with regard to disability pensions. A case-controlled study among unskilled workers]. (1989) (12)
- Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population‐based cohort study (2016) (12)
- Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? (2016) (12)
- Characteristics of children with acute lymphoblastic leukemia presenting with arthropathy (2018) (12)
- Mitochondrial 12S ribosomal RNA A1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure. (2014) (11)
- Parvovirus B19 infection infrequently involved in children and adults with myelodysplastic syndrome. (1996) (11)
- The long non-coding RNA landscape in juvenile myelomonocytic leukemia (2018) (11)
- Hyperleucocytosis in paediatric acute myeloid leukaemia – the challenge of white blood cell counts above 200 × 109/l. The NOPHO experience 1984–2014 (2017) (11)
- Social conditions for people with Down syndrome: A register‐based cohort study in Denmark (2014) (11)
- Somatic late effects in 5‐year survivors of neuroblastoma: a population‐based cohort study within the Adult Life after Childhood Cancer in Scandinavia study (2018) (11)
- Central Venous Catheters and Bloodstream Infection During Induction Therapy in Children With Acute Lymphoblastic Leukemia (2016) (11)
- ATYPICAL CHRONIC MYELOID LEUKAEMIA AND CHRONIC MYELOMONOCYTIC LEUKAEMIA IN CHILDREN (1995) (10)
- Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children (2020) (10)
- Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries. (2019) (10)
- Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. (2011) (10)
- T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS (2014) (10)
- Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance. (2005) (10)
- Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child‐specific reference values (2019) (10)
- Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators (2021) (10)
- Late mortality and morbidity among long‐term leukemia survivors with Down syndrome: A nationwide population‐based cohort study (2018) (10)
- Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia (2018) (10)
- COVID-19 – Impact on Childhood Haematology Patients (2020) (10)
- Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO‐AML study (2016) (9)
- [The significance of working conditions with regard to disability pensions. A case-controlled study among unskilled workers]. (1989) (9)
- Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML. (2010) (9)
- Complex Three-Way Translocation Involving MLL, ELL, RREB1, and CMAHP Genes in an Infant with Acute Myeloid Leukemia and t(6;19;11)(p22.2;p13.1;q23.3) (2013) (9)
- Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study (2018) (9)
- Germline GATA1s generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype. (2021) (9)
- Contribution of multiparameter genetic analysis to the detection of genetic alterations in hematologic neoplasia. An evaluation of combining G-band analysis, spectral karyotyping, and multiplex reverse-transcription polymerase chain reaction (multiplex RT-PCR). (2006) (9)
- Use of granulocyte colony‐stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO‐AML 2004 and DB AML‐01 (2019) (9)
- Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia (2018) (8)
- Childhood conditions and adult height (1991) (8)
- Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I‐BFM analysis of 333 children (2020) (8)
- Acute renal failure and normal blood count: A rare presentation of T-cell acute lymphoblastic leukemia☆ (2013) (8)
- A novel splice mutation in the TP53 gene associated with Leydig cell tumor and primitive neuroectodermal tumor (2008) (8)
- Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia. (2009) (8)
- Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)? (2010) (8)
- Clonal Mutational Landscape of Childhood Myelodysplastic Syndromes (2015) (7)
- Hyperthyroidism as a late effect in childhood cancer survivors - an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study (2019) (7)
- Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse (2021) (7)
- Treatment‐related deaths in second complete remission in childhood acute myeloid leukaemia (2011) (7)
- A novel RT‐qPCR assay for quantification of the MLL‐MLLT3 fusion transcript in acute myeloid leukaemia (2013) (7)
- Acute Respiratory Failure in 3 Children With Juvenile Myelomonocytic Leukemia (2011) (7)
- Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I‐BFM) study group (2018) (7)
- Liver diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population‐based cohort study of 32,839 one‐year survivors (2018) (7)
- Acute Lymphoblastic Leukemia Presenting With Pancytopenia Followed by a 14-Month-Long Period of Transient Remission Possibly Supporting the Adrenal Hypothesis of Leukemogenesis (2016) (7)
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia ( JMML ) with poor outcome (2011) (7)
- Cancer Screening in Li-Fraumeni Syndrome. (2017) (7)
- LIN 28 B overexpression de fi nes a novel fetal-like subgroup of juvenile myelomonocytic leukemia (2016) (6)
- Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2. (2018) (6)
- Chronic myelomonocytic leukemia (CMML) in childhood (1994) (6)
- Children with low‐risk acute lymphoblastic leukemia are at highest risk of second cancers (2017) (6)
- SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature (2021) (6)
- Pain intensity and bioavailability of intramuscular asparaginase and a local anesthetic: A double‐blinded study (2005) (6)
- SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation (2018) (6)
- Prolonged extreme thrombocytosis associated with neurofibromatosis type 1. (1997) (5)
- High Frequency of GATA1 Mutations in Childhood Non-Down Syndrome Acute Megakaryoblastic Leukemia (2012) (5)
- Incidence and survival of childhood central nervous system tumors in Denmark, 1997–2019 (2021) (5)
- Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO‐DBH‐AML study (2018) (5)
- Autoimmune Hepatitis and Seronegative Hepatitis Associated With Myelodysplastic Syndrome in Children (2016) (5)
- Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark (2018) (5)
- Measuring childhood cancer late effects: evidence of a healthy survivor effect (2017) (5)
- JMML Revisited: Role Und Outcome of Hematopoietic Stem Cell Transplantation in Subtypes of Juvenile Myelomonocytic Leukemia (JMML) (2012) (5)
- [Occurrence of cancer in individuals with Down syndrome]. (2000) (5)
- Skeletal adverse events in childhood cancer survivors: An Adult Life after Childhood Cancer in Scandinavia cohort study (2021) (4)
- Acute lymphoblastic leukemia with Philadelphia chromosome in a 39-year-old woman with Down syndrome presenting as meningitis and fulminant liver failure. (2010) (4)
- [Morbidity among children attending nursery schools]. (1989) (4)
- Neurologic disorders in long-term survivors of neuroblastoma – a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program (2020) (4)
- Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study (2021) (4)
- Association of Unbalanced Translocation der(1;7) with Germline GATA2 Mutations. (2021) (4)
- Home‐based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial (2020) (4)
- Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme. (2021) (4)
- Anthracycline type during induction associated with outcome in pediatric t(8;21) and inv(16) AML (2014) (4)
- Impact of Somatic Mutations on the Outcome of Children and Adolescents with Therapy-Related Myelodysplastic Syndrome (2016) (4)
- Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971-2008 in Denmark, Finland, and Sweden: A population-based cohort study. (2021) (4)
- Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia. (2009) (4)
- Tubulointerstitial Nephritis in a Patient With Probable Autoimmune Lymphoproliferative Syndrome (2013) (4)
- Psychotropic medication in the elderly. A survey of prescribing and clinical outcome. (1990) (4)
- Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia (2019) (4)
- Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study (2010) (3)
- The breakpoints of a constitutional inversion of chromosome 9 associated with haemophagocytic lymphohistiocytosis are not linked to the disease gene (1999) (3)
- A case of childhood acute myeloid leukemia associated with inversion (7)(p21q31). (1999) (3)
- Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease (2012) (3)
- Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome (2016) (3)
- [Shark liver oil (alkoxyglycerol) and cancer treatment]. (1991) (3)
- Employment status and occupational positions of childhood cancer survivors from Denmark, Finland and Sweden: A Nordic register-based cohort study from the SALiCCS research programme (2021) (3)
- Novel mutation of the LPIN2 gene in Turkish brothers with Majeed syndrome. Response to IL-1 inhibition (2011) (3)
- What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort (2021) (3)
- Analysis of rare driving events in pediatric acute myeloid leukemia (2022) (3)
- Treatment-related Myelodysplastic Syndrome in a Child With Acute Myeloid Leukemia and TPMT Heterozygosity (2015) (3)
- Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups. (2004) (3)
- Long-term results of the 'Prospective study of the diagnosis and treatment of myelodysplastic syndromes in childhood (EWOG-MDS98)' (2015) (3)
- ABO, secretor, and Lewis carbohydrate histo‐blood groups are associated with autoimmune neutropenia of early childhood in Danish patients (2022) (3)
- Turner syndrome and myelodysplastic syndrome. No reason to alert. (1997) (3)
- Musculoskeletal Diagnoses Prior to Cancer in Children: A Danish Registry-Based Cohort Study. (2021) (3)
- Hematological Changes Mimicking Myelodysplastic Syndrome Following Treatment for Osteosarcoma (2015) (3)
- Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium (2022) (3)
- Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset (2020) (2)
- Gemtuzumab Ozagamicin Is Well Tolerated as Post-Consolidation Therapy in Childhood AML. (2007) (2)
- Cellular drug sensitivity in childhood acute myeloid leukemia : On behalf of the Nordic Society for Paediatric Haematology and Oncology (2008) (2)
- C030 Hematopoietic stem cell transplantation after a myeloablative conditioning regimen in children with refractory cytopenia: results of a retrospective analysis from the EWOG-MDS group (2007) (2)
- DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML) (2021) (2)
- Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries (2021) (2)
- Abstract of papers presented at the Third International Symposium on Myelodysplastic SyndromesEpidemiology of MDS in childhood (1994) (2)
- Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study (2010) (2)
- Disease‐specific hospitalizations among 5‐year survivors of Wilms tumor: A Nordic population‐based cohort study (2021) (2)
- Hematopoietic Stem Cell Transplantation (HSCT) after a Myeloablative Conditioning Regimen in Children with Refractory Cytopenia (RC): Results of a Retrospective Analysis from the EWOG-MDS Group. (2007) (2)
- C029 Hematopoietic stem cell transplantation for advanced primary MDS in children: results of a retrospective analysis from the EWOG-MDS group (2007) (2)
- Abdominal Complications During Treatment for Pediatric Acute Myeloid Leukemia (2021) (2)
- Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016 (2017) (2)
- Classification of rare pediatric myeloid neoplasia—Quo vadis? (2022) (2)
- Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma (2019) (2)
- Identification of novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia (2009) (2)
- Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia (2018) (2)
- Splenectomy in two children with autoimmune lymphoproliferative syndrome and massive splenomegaly (2009) (2)
- adolescents: recommendations from an international expert panel Diagnosis and management of acute myeloid leukemia in children and (2013) (2)
- The Prognostic Impact of Cytogenetics and Karyotype Changes in Pediatric Patients with Relapsed Acute Myeloid Leukemia: A Retrospective Cohort Study within the Relapsed AML 2001/01 Study (2016) (1)
- Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group (2022) (1)
- Constitutional SAMD9L Mutations Cause Familial Myelodisplastic Syndrome with Monosomy 7 and Stable Revertant Mosaicism (2017) (1)
- leukemia: results from the NOPHO ALL-92 study of a second malignant neoplasm after childhood acute lymphoblastic Methotrexate/6-mercaptopurine maintenance therapy influences the risk (2013) (1)
- Osteonecrosis requiring total joint arthroplasty is a rare sequel in children and young adults treated for solid tumors (2014) (1)
- Outcome of (Novel) Subgroups in 1257 Pediatric Patients with KMT2A-Rearranged Acute Myeloid Leukemia (AML) and the Significance of Minimal Residual Disease (MRD) Status: A Retrospective Study By the I-BFM-SG (2020) (1)
- Clinical characteristics of patients with JMML according to mutational status (2006) (1)
- Cohort Profile: The Socioeconomic Consequences in Adult Life After Childhood Cancer in Scandinavia (SALiCCS) Research Programme (2021) (1)
- Parvovirus B-19 induced anemia as a presenting manifestation of X-linked hyper IgM syndrome (XHIM) (1998) (1)
- NF1 Tumor Suppressor Gene Inactivation in Juvenile Myelomonocytic Leukemia: New Genetic Evidence and Consequences for Diagnostic Work-up (2020) (1)
- Factors influencing participation rates in clinical late effect studies of childhood cancer survivors (2021) (1)
- High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response (2012) (1)
- Effect of Age and Weight on Toxicity and Survival in Pediatric Acute Myeloid Leukemia (2015) (1)
- Hyperdiploidy in Childhood AML Associated with Low Age and AML-M7. A NOPHO-AML Study and Literature Review, (2011) (1)
- Hypodiploidy in Childhood Acute Myeloid Leukemia: A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study Group (2018) (1)
- RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, (2013) (1)
- Translocation t(6;9)(p22;q34)/DEK-NUP214 rearranged Pediatric AML: A Retrospective International Study (2012) (1)
- Long Non-Coding RNAs As Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Proof of Concept Study (2019) (1)
- Arthritis as presenting manifestation of acute lymphoblastic leukemia in children (2014) (1)
- Chronic myelomonocytic leukemia (CMML) in childhood. (Abstract) (1994) (1)
- Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium (2022) (1)
- Esophageal disease among childhood cancer survivors—A report from the Childhood Cancer Survivors Study (2021) (1)
- Measurable residual disease monitoring of SPAG6, ST18, PRAME, and XAGE1A expression in peripheral blood may detect imminent relapse in childhood acute myeloid leukemia. (2021) (1)
- Efficacy, Safety, and Pharmacokinetics (PK) of Azacitidine (AZA) in Children and Young Adults with Acute Myeloid Leukemia (AML) in the Phase 2 AZA-AML-004 Trial (2020) (1)
- Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL‐2 expression by cytogenetic subgroups (2022) (1)
- A Molecular Signature of the Transcription Factor GATA1 in Acute Megakaryoblastic Leukemia of Childhood. (2004) (1)
- Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (INTERACT): Study Protocol for a Multicenter, Two-Arm Parallel-Group Randomized Controlled Superiority Trial (2022) (1)
- Hospitalizations in long‐term survivors of childhood AML treated with allogeneic HCT—An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study (2020) (1)
- Childhood Leukemias: Myelodysplastic syndrome (2006) (1)
- Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study (2015) (1)
- [Fatal thrombocytopenia triggered by quinidine]. (1989) (1)
- Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia (2013) (1)
- Hospital admission for neurologic disorders among 5‐year survivors of noncentral nervous system tumors in childhood: A cohort study within the Adult Life after Childhood Cancer in Scandinavia study (2019) (1)
- Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40) (2015) (1)
- Effect on Parental Distress of a Home-based Psychological Intervention for Families of Children with Cancer (FAMOS): A Nationwide Randomized Controlled Trial (2019) (1)
- Osteoporotic Fractures in Childhood Cancer Survivors - ALICCS Cohort Study (2018) (1)
- Risk of late health effects after soft-tissue sarcomas in childhood – a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia research programme (2020) (1)
- Inhibition of GM-CSF prevents dissemination and induces remission of human juvenile myelomonocytic leukemia in engrafted immunodeficient mice. (1997) (1)
- CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. (2016) (1)
- M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis (2021) (1)
- Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses (2019) (1)
- The Applicability Of The WHO Classification In Pediatric AML. A NOPHO-AML Study (2013) (1)
- Reply to Gassas et al (2003) (1)
- The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study. (2021) (1)
- Age and Prognosis in Pediatric AML (2008) (1)
- Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group (2020) (1)
- Subcutaneous (sc) Anti-D Treatment of Childhood Idiopathic Thrombocytopenic Purpura (ITP). (2007) (0)
- Markers of neutrophil chemotaxis for identification of blood stream infections in children with acute lymphoblastic leukemia undergoing induction treatment (2023) (0)
- qPCR MRD Monitoring in Peripheral Blood May Predict Hematological Relapse in Pediatric Acute Myeloid Leukemia (2015) (0)
- Syddansk Universitet Clinical characteristics and registry-validated extended pedigrees of germline TP 53 mutation carriers in Denmark (2018) (0)
- Second International Symposium on Myelodys plastic Syndrome in Childhood: Meeting report (2001) (0)
- Factors influencing participation rates in clinical late‐effect studies of childhood cancer survivors (2021) (0)
- Genetic variations in low‐to‐medium‐affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort (2023) (0)
- Molecular Aberrations in 107 Children with Myelodysplastic Syndrome (MDS). (2012) (0)
- Quantification of Fusion Transcripts Reveals Slower Treatment Kinetics As Compared with Multiparameter Flow Cytometry during Induction Treatment of Acute Myeloid Leukemia in Children (2018) (0)
- Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes (2021) (0)
- UBTF tandem Duplications Account for a Third of Advanced Pediatric MDS without Genetic Predisposition to Myeloid Neoplasia (2022) (0)
- Secondary leukemia (2018) (0)
- The Integrated Immunological Signature of Refractory Cytopenia of Childhood (RCC) (2015) (0)
- Toxicity is Associated with Age in Nopho-Aml 2004 (2014) (0)
- international study -rearranged AML patients: results of an MLL novo pediatric 11q23/ Prognostic significance of additional cytogenetic aberrations in 733 de (2011) (0)
- Relapse Prediction in AML Patients in Complete Remission Using WT1 as a Molecular Marker: Development of a Mathematical Model To Predict Time from Molecular to Clinical Relapse and Define Optimal Sampling Intervals. (2007) (0)
- Inflammatory Biomarkers Can Differentiate ALL with Arthropathy from JIA Better Than Standard Blood Tests. (2023) (0)
- 48 Gata2-Related Myelodysplastic Syndromes (Mds): Prevalence, Clinical Characteristics and Prognosis (2015) (0)
- Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group. (2023) (0)
- Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment (2021) (0)
- Long-Term Risk of Hospitalization for Somatic Diseases Among Survivors of Childhood Acute Lymphoblastic Leukemia (2022) (0)
- Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study (2021) (0)
- JAK2 gene mutation is not a common event in JMML and is not involved in the pathogenesis of the disease (2006) (0)
- Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study (2019) (0)
- Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (0)
- Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia (2022) (0)
- Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia (2018) (0)
- Mutations of the Spliceosome Complex Genes Occur In Adult Patients but Are Very Rare In Children with Myeloid Neoplasia (2011) (0)
- Mathematical Modeling of Molecular Relapse Kinetics in NPM1c+, PML-Rara+, RUNX1-RUN1T1+, and CBFB-MYH11+ Acute Myeloid Leukemias (2008) (0)
- WT1 as MRD marker in myeloid leukemia of Down syndrome (2009) (0)
- Myelodysplastic Syndrome, Myeloid Leukaemia of Down Syndrome, and Juvenile Myelomonocytic Leukaemia (2020) (0)
- Good General Health In Survivors of Childhood AML Treated with Chemotherapy Only: A NOPHO-AML Study. (2010) (0)
- t(6;9)(p22;q34) DEK/NUP214 in Childhood (2018) (0)
- Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study (2019) (0)
- Hepatotoxicity in Patients Treated with Gemtuzumab Ozogamicin - Specific Targeting of Hepatocytes? (2009) (0)
- Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms? (2009) (0)
- Central venous catheters and bloodstream infections during induction therapy for acute lymphoblastic Leukemia: A multi-institutional cohort study in Denmark (2015) (0)
- Glucocorticosteroid and Silicone Gel During Patch Application Without Clinical Scar Improvement After Central Venous Catheter Removal: A Randomized Trial (2022) (0)
- Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration (2022) (0)
- C026 Childhood refractory cytopenia: clinical, hematological features and response to immunosuppression (2007) (0)
- Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^ (2021) (0)
- O-45 Treatment for patients relapsingwith juvenile myelomonocytic leukemia after allogeneic stem cell transplantation: The EWOG-MDS study (2005) (0)
- eScholarship Title Study protocol : rehabilitation including social and physical activity and education in children and teenagers with cancer ( RESPECT ) Permalink (2013) (0)
- Usefulness of Current Candidate Genetic Markers to Identify Childhood Cancer Patients at Risk for Platinum-Induced Ototoxicity: Results of the European PanCareLIFE Cohort Study (2020) (0)
- Hospitalizations among persons with Down syndrome : a national cohort study in Denmark (2015) (0)
- Characteristics and outcome of treatment-related MDS after childhood cancer: The EWOG-MDS experience (2006) (0)
- Temporal changes in the probability of live birth among female survivors of childhood cancer: A population‐based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five nordic countries (2021) (0)
- Comparison of two consecutive cohorts of childhood acute myeloid leukemia in Hong Kong (2013) (0)
- [Consumption of psychopharmaceuticals by residents at nursing homes. Significance of the environment at the nursing home]. (1989) (0)
- Effects on Pediatric Cancer Survivors: The FAMily-Oriented Support (FAMOS) Randomized Controlled Trial. (2022) (0)
- [Genetic prevention of cancer]. (2000) (0)
- The Molecular Characteristics and Clinical Relevance of NUP98-Other Translocations in Pediatric Acute Myeloid Leukemia (2020) (0)
- Den objektive strukturerede kliniske eksamen som led i speciallaegeuddannelsen i paediatri. De første danske erfaringer (2000) (0)
- [Allergy presumed by parents of children in nursery schools and day care in relation to conditions of care]. (1989) (0)
- Cytogenetics in Pediatric MDS - Data of the EWOG-MDS 98 Study. (2005) (0)
- Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. (2023) (0)
- Neurocognitive function and health-related quality of life in a nationwide cohort of long-term childhood brain tumor survivors. (2022) (0)
- BRAF Mutations in Juvenile Myelomonocytic Leukemia. (2007) (0)
- Treatment of Molecular Relapse by Cessation of Immunosuppression After Hematopoietic Stem Cell Transplantation in Pediatric FLT3-ITD AML Monitored by WT1 Expression in Peripheral Blood. (2019) (0)
- SIGNIFICANCE OF MONOSOMY 7 IN MYELOID LEUKEMIAS IN CHILDREN (2000) (0)
- Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia (2023) (0)
- s urvival among people with d own syndrome: a nationwide population-based study in d enmark (2012) (0)
- [The social and medical characteristics of persons retiring early in Odense before and after the Danish legislation on social pensioning in 1984]. (1987) (0)
- 234 Role of mitochondrial DNA mutations in childhood MDS (2011) (0)
- Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution (2021) (0)
- Phagocyte-related S100 proteins and cytokines in acute lymphoblastic leukemia and their prognostic value. (2023) (0)
- [Human herpesvirus 6. The etiological agent in exanthema subitum]. (1993) (0)
- 232 Relevance of WT1 expression, mutations and single nucleotide polymorphisms in juvenile myelomonocytic leukemia (2011) (0)
- Second International Symposium on myelodysplastic syndrome in childhood, Hindsgavl castle, Fyn, Denmark, May 11-14, 2000. (2001) (0)
- Subcutaneous Anti-D as Treatment of Idiopathic Thrombocytopenic Purpura in Children; Clinical Observations. (2005) (0)
- ” HNA specificity and association to HLA-DRB1 and -DQB1 in patients with autoimmune neutropenia of early childhood” (2023) (0)
- IER3 expression in childhood myelodysplastic syndrome (2011) (0)
- Childhood Myelodysplastic Syndromes Treated with Acute Myeloid Leukemia Regimens (1997) (0)
- Kidney disease in very long‐term survivors of Wilms tumor: A nationwide cohort study with sibling controls (2022) (0)
- Impact of MRD status prior to HSCT in pediatric AML (2013) (0)
- Characteristics and Outcome of Therapy-Related MDS Developing after Primary Cancer in Children. (2005) (0)
- leukemia (JMML)? contribute to leukemogenesis in juvenile myelomonocytic SPRED1 Does (2012) (0)
- The Prognostic Impact of Blast Cell Immunophenotyping in Intermediate Risk AML Patients at Diagnosis. (2004) (0)
- 293 FAMILIAL MYELODYSPLASTIC SYNDROME (MDS) IN TWO DANISH FAMILIES - TWO NEW PREDISPOSING TERC MUTATIONS IDENTIFIED (2015) (0)
- Aberrant DNA Methylation Characterizes a Subtype of Juvenile Myelomonocytic Leukemia (JMML) with Poor Outcome. (2009) (0)
- O-42 Diagnostic pitfalls in childhoodMDS and JMML (2005) (0)
- AML in children. Experiences from the NOPHO studies (2006) (0)
- Cancer in Down syndrome (2001) (0)
- Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients (2022) (0)
- Association between Fc-Gamma Receptor Polymorphisms and Autoimmune Neutropenia in Early Childhood in Danish Patients (2022) (0)
- THE EUROPEAN ROADMAP TO HORIZON 2020 FOR CHILDREN AND ADOLESCENTS WITH CANCER - A LONG TERM SUSTAINABLE STRATEGY (2015) (0)
- Risk of Second Malignant Neoplasm Is Related to TPMT Activity and Duration of MTX/6MP Maintenance Therapy of ALL. (2006) (0)
- Risk-adapted treatment of acute promyelocytic leukemia : results from International Consortium for Childhood APL Running title : risk-adapted therapy for childhood APL (2018) (0)
- High Frequency of Copy Number Variations in Myeloid Leukemia of Down Syndrome. (2009) (0)
- A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure (2020) (0)
- PF677 DNA HYPERMETHYLATION EMERGES AS THE STRONGEST PREDICTOR FOR POOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) (2019) (0)
- Treatment Outcomes of Childhood Picalm:MLLT10+ Acute Leukemias: An International Retrospective Study (2022) (0)
- A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS. (2007) (0)
- 2012 – ADAPTIVE AND MALADAPTIVE SOMATIC RESCUE MOSAICISM IN SAMD9 AND SAMD9L SYNDROMES EXEMPLIFIES THE HIGH PLASTICITY OF HEMATOPOIESIS EARLY IN LIFE (2021) (0)
- [Unrecognized occupational diseases among unskilled workers having chosen early retirement]. (1988) (0)
- Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment (2021) (0)
- prognostic markers in childhood acute myeloid leukemia expression are independent BAALC-ITD and high FLT 3 Presence of (2011) (0)
- Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML. (2009) (0)
- GLUCOCORTICOSTEROID DURING PATCH APPLICATION TO IMPROVE SCAR OUTCOME AFTER CENTRAL VENOUS CATHETER. A RANDOMIZED TRIAL (2021) (0)
- Identification of a MEF Gene Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient That Decreases MEF Transcriptional Activity. (2005) (0)
- Mutation Analysis of JAK-1, 2 and 3 in Children with Down Syndrome and Acute Leukemia. (2009) (0)
- Exploring the long non-coding RNA landscape in juvenile myelomonocytic leukemia (2018) (0)
- Immature platelet fraction in children; reference interval and assessment of clinical utility in peciatric patients with malignant disorders (2009) (0)
- Extreme hyperleukocytosis in a pediatric T-ALL patient with a rare translocation, t(7;19)(q35;p13), and submicroscopic deletions at 4q25, 7q33 and 10q23☆ (2013) (0)
- European standard clinical practice - Key issues for the medical care of individuals with familial leukemia. (2023) (0)
- Juvenile myelomonocytic leukemia : five genes, how many subtypes? (2014) (0)
- Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft (2023) (0)
- Myelodysplastic syndromes in adolescents: characteristics and clinical outcome (2009) (0)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with GATA2-Related Myelodysplastic Syndrome (2019) (0)
- [Unrecognized Hodgkin's disease as cause of death. A review of 27 cases diagnosed post mortem]. (1993) (0)
- myeloid leukemia: results of an international retrospective study Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute (2013) (0)
- P079 BRAF mutations in juvenile myelomonocytic leukemia (2007) (0)
- 233 IER3 in childhood myelodysplastic syndrome (2011) (0)
- AZACITIDINE (VIDAZA®) IN PEDIATRIC PATIENTS WITH RELAPSED ADVANCED MDS: RESULTS OF A PHASE I/II STUDY BY THE ITCC CONSORTIUM AND THE EWOG-MDS GROUP: STUDY ITCC-015 (2019) (0)
- [The objective structured clinical examination in postgraduate pediatric training. The first Danish experiences]. (2000) (0)
- Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia (2019) (0)
- Therapy-Related Myelodysplastic Syndrome Following Treatment for Childhood Acute Lymphoblastic Leukemia: Outcome of Patients Registered in the EWOG-MDS 98/06 Studies, (2011) (0)
- Latemortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population-based cohort study (2021) (0)
- Mutation landscape in childhood myelodysplastic syndromes : results from EWOG-MDS (2016) (0)
- JMML and Myelodysplastic Syndrome in Children (2011) (0)
- Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™). (2007) (0)
- Refractory Cytopenia In Childhood (RCC) with Normal Karyotype Is Unlikely to Progress to Advanced MDS Under a Watch and Wait Strategy (2010) (0)
- Childhood MDS treated with AML regimens (1994) (0)
- Mutational Screening in refractory cytopenia - in search of underlying SDS. (2009) (0)
- Treatment of JMML other than stem cell transplantation: A retrospective analysis of 129 treatment courses in 63 patients (2006) (0)
- RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia (2017) (0)
- Growth hormone deficiency in adult survivors of childhood brain tumors treated with radiation (2022) (0)
- Stem cell transplantation for therapy-related myelodysplastic syndrome following treatment for childhood acute lymphoblastic leukaemia (2011) (0)
- Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: THE EVOLVING GENETIC LANDSCAPE OF PEDIATRIC MDS-EB (2023) (0)
- Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome. (2023) (0)
- Pediatric Acute Megakaryoblastic Leukemia without Down Syndrome: A Retrospective Study by the International Berlin-Frankfurt-Munster Study Group (I-BFMSG) (2014) (0)
- prevent relapse in children with AML: results from NOPHO-AML 2004 Gemtuzumab ozogamicin as postconsolidation therapy does not (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Henrik Hasle?
Henrik Hasle is affiliated with the following schools:
